An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
Autor: | Drake, M J, Robson, W, Mehta, P, Schofield, I, Neal, D E, Leung, H Y |
---|---|
Zdroj: | British Journal of Cancer. 3/24/2003, Vol. 88 Issue 6, p822. 6p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |